Neogen Corporation Deferred State and Local Income Tax Expense (Benefit)
Neogen Corporation (NEOG) reported Deferred State and Local Income Tax Expense (Benefit) of -$3.60 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-07-30
- Neogen Corporation deferred state and local income tax expense (benefit) for fiscal 2026 was -$3.60M.
- Neogen Corporation deferred state and local income tax expense (benefit) for fiscal 2025 was -$3.40M.
- Neogen Corporation deferred state and local income tax expense (benefit) for fiscal 2024 was -$4.90M.
- Neogen Corporation deferred state and local income tax expense (benefit) for fiscal 2023 was -$1.86M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2026-05-31 | -$3.60M 10-K · filed 2026-07-30 | |
| 2025-05-31 | -$3.40M 10-K · filed 2026-07-30 | -$3.37M 10-K · filed 2025-07-30 |
| 2024-05-31 | -$4.90M 10-K · filed 2026-07-30 | -$4.88M 10-K · filed 2024-07-30 |
| 2023-05-31 | -$1.86M 10-K · filed 2025-07-30 | |
| 2022-05-31 | -$356.00K 10-K · filed 2024-07-30 | |
| 2021-05-31 | $44.00K 10-K · filed 2023-08-15 | |
| 2020-05-31 | $195.00K 10-K · filed 2022-07-27 | |
| 2019-05-31 | $98.00K 10-K · filed 2021-07-30 | |
| 2018-05-31 | -$355.00K 10-K · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |